The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 33 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
The aim of the Associations, which has no profit-making purpose, is to promote pharmaceutical discovery and development in Europe and to bring to the market medicinal products in order to improve human health worldwide. Europe needs and deserves healthcare systems that take a modern approach to both demand and delivery. 21st century healthcare systems should benefit the needs of European countries, which are faced with unprecedented challenges to its social model growth. The vision of the pharmaceutical industry is one of cooperation and partnerships: A collaborative approach will maximise the benefits we can deliver to society together through developing innovative medicines.
We support a vision of outcomes-driven, sustainable healthcare systems in Europe. We want systems that provide patients with equal and early access to the best and safest medicines; that support innovation while balancing realistically benefit and risk; that empowers citizens to make informed decisions about their health and ensure the highest security of the medicines supply chain. Such a vision will also assist policymakers in sustaining Europe’s economic growth and competitiveness, by balancing healthcare budgets and helping to provide for a healthy and productive workforce. It also offers the most effective approach to deliver the innovative medicines needed to tackle current and potential health threats.
Improving patient outcomes, developing sustainable models of healthcare, reducing inequalities in health, accelerating patients’ access to innovative medicines and improving patient safety – these are our primary commitments. By working in partnership with all healthcare stakeholders, we seek to develop practical solutions to make these goals a reality.
We believe that these commitments are in the best interest of Europe’s citizens. We will engage with all partners in healthcare delivery to discuss, design and implement policies that help us achieve these goals, while improving public health and economic wealth, as well as enhancing Europe’s industrial and science base.
European Biopharmaceutical Enterprises (EBE) represents the voice of biopharmaceutical companies of all sizes in Europe and is a specialised group within EFPIA. Established in 2000, EBE is recognised as the leading biopharmaceutical association in Europe.
Vaccines Europe (VE) is the specialised vaccine industry group within EFPIA. It represents major innovative research-based global vaccine companies as well as small and medium sized enterprises operating in Europe.